MECOM and pancreatic neoplasm: In contrast to KrasG12D-Prdm3ΔAcinar mice, tumor budding was rarely observed in KrasG12D mice, suggesting that loss of Prdm3 accelerates pancreatic cancer formation in KrasG12D-expressing mice.